Adenovirus DNA binding protein inhibits SrCap-activated CBP and CREB-mediated transcription

Xiequn Xu1, Vera Tarakanova, John Chrivia

  • 1Department of Molecular Microbiology and Immunology, Saint Louis University Health Sciences Center, Saint Louis, MO 63104, USA.

Virology
|September 5, 2003
PubMed

Insights

Adenovirus 2 DNA Binding Protein (DBP) inhibits transcription mediated by SNF2-related CBP activator protein (SrCap). DBP specifically blocks SrCap

Area of Science:

  • Molecular Biology
  • Gene Regulation
  • Transcription Factors

Background:

  • SNF2-related CBP activator protein (SrCap) is a key mediator of transcription involving CBP and CREB.
  • Adenovirus 2 DNA Binding Protein (DBP) has been shown to bind SrCap and inhibit its carboxyl-terminal activity.

Purpose of the Study:

  • To investigate the effect of DBP on the transcriptional activity of full-length SrCap.
  • To determine if DBP's inhibitory effect on SrCap is specific.

Main Methods:

  • Assessed the impact of DBP on SrCap-mediated transcription using Gal-CREB and Gal-CBP systems.
  • Evaluated DBP's effect on Protein Kinase A (PKA)-activated transcription of the enkephalin promoter.
  • Utilized a mammalian two-hybrid system to examine DBP's inhibition of SrCap-CBP interactions.
  • Tested DBP's effect on a non-SrCap-related transcriptional activator to assess specificity.

Main Results:

  • DBP significantly inhibits the transcriptional activation mediated by full-length SrCap.
  • DBP suppresses PKA-activated transcription of the enkephalin promoter via SrCap.
  • DBP dramatically inhibits transcription in a mammalian two-hybrid system dependent on SrCap-CBP interaction.
  • DBP's inhibitory effect is specific to SrCap, as it does not affect unrelated transcriptional activators.

Conclusions:

  • DBP acts as a specific inhibitor of SrCap-mediated transcription.
  • The findings support a model where DBP interferes with the SrCap-CBP interaction to inhibit cellular transcription.

Related Concept Videos

RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...